HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

Lead monoxide → Lead oleate

HRID 1271790
Print

Reaction equation

HRID 1271790 reaction equation
O.O.O.C([O-])(=O)C.[Pb+2:8].C([O-])(=O)C.[Pb]=O.[C:15]([OH:34])(=[O:33])[CH2:16][CH2:17][CH2:18][CH2:19][CH2:20][CH2:21][CH2:22]/[CH:23]=[CH:24]\[CH2:25][CH2:26][CH2:27][CH2:28][CH2:29][CH2:30][CH2:31][CH3:32]>C1(OC2C=CC=CC=2)C=CC=CC=1>[C:15]([O-:34])(=[O:33])[CH2:16][CH2:17][CH2:18][CH2:19][CH2:20][CH2:21][CH2:22]/[CH:23]=[CH:24]\[CH2:25][CH2:26][CH2:27][CH2:28][CH2:29][CH2:30][CH2:31][CH3:32].[Pb+2:8].[C:15]([O-:34])(=[O:33])[CH2:16][CH2:17][CH2:18][CH2:19][CH2:20][CH2:21][CH2:22]/[CH:23]=[CH:24]\[CH2:25][CH2:26][CH2:27][CH2:28][CH2:29][CH2:30][CH2:31][CH3:32]
ParticipantsConditionsProcedureSources & evidenceReaction notes

Participants

5

Reactant 3

HCID 14827Lead monoxideHCID 22456Lead diacetate trihydrateHCID 445639Oleic Acid

Product 1

HCID 6435829Lead oleate

Reagents, catalysts & solvents 1

HCID 7583Diphenyl EtherSolvent

Conditions

Temperature
150 °C

Procedure

1.421 g of lead acetate trihydrate (or lead oxide (PbO)) and 5 ml oleic acid were added into a reaction vessel containing 20 ml diphenyl ether solution and heated to a temperature of about 150° C. for 30 min to form a lead oleate. After cooling to 60° C., this solution was mixed with 12 ml TOPSe (or TOPTe) stock solution to prepare injecting precursor. Reaction was carried out at various injecting and reaction temperatures. Also various molar ratio of lead oleate to TOPSe stock solutions were tested for injecting precursor to find the optimum conditions of reaction. Typically, injecting the precursor solution at 130° C. of 30 ml diphenylether solution and keeping the reaction temperature at 110° C. for 5 min yielded approximately 5 nm sphere PbSe quantum dots. For the synthesis of larger size (>10 nm) cubic shape PbSe dots, lower injecting temperatures (<110° C.) or second injection of additional precursors at about 30% the amount of that in the first injection after the nucleation have been used were used

Sources & evidence

ORD record
ord-12f424452d61452da98fb58b50cfe4e8
Source dataset
uspto-grants-2007_04
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US07208133B2

Reaction notes

On this pageParticipantsConditionsProcedureSources & evidenceReaction notes